Luis Dellamary

Mr. Dellamary is a drug development and manufacturing leader with over 28 years of industry experience. Prior to joining Endeavor, Luis worked at Gossamer Bio. He has also worked at Samumed LLC., Otonomy, Amylin, Targegen, Isis Pharmaceutical and Alliance Pharmaceuticals. Mr. Dellarmary holds 60 US patents and has 89 pending applications. He has been involved in the development of three commercial drug products (TOBI Podhaler, INREBIC and OTIPRIO).